Authors
Loading...
Research demonstrates the role of G1 cyclin-dependent kinase inhibitors in tumor cell biology, indicating potential therapeutic implications.
Sherr et al. (1995) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: